Methylprednisolone Concentrations in Breast Milk and Serum of Patients with Multiple Sclerosis Treated with IV Pulse Methylprednisolone

Karahan S. Z. , BOZ C. , Terzi M., Aktoz G., Sen S., Ozbudun B., ...Daha Fazla

CLINICAL NEUROLOGY AND NEUROSURGERY, cilt.197, 2020 (SCI İndekslerine Giren Dergi) identifier identifier identifier


Background: It is commonly known that women with multiple sclerosis (MS) have an increased risk for relapses during the post-partum period. High-dose IV methylprednisolone is the first-line treatment for acute relapses. Methylprednisolone is administered to lactating women although there is insufficient data as to the levels of concentration in breast milk and serum, and the calculated steroid exposure to infants.